310 related articles for article (PubMed ID: 15046253)
1. Molecular mechanisms and biological significance of CTL avidity.
Snyder JT; Alexander-Miller MA; Berzofskyl JA; Belyakov IM
Curr HIV Res; 2003 Jul; 1(3):287-94. PubMed ID: 15046253
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of high avidity CTL by altering the balance of signals from APC.
Oh S; Hodge JW; Ahlers JD; Burke DS; Schlom J; Berzofsky JA
J Immunol; 2003 Mar; 170(5):2523-30. PubMed ID: 12594278
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
[TBL] [Abstract][Full Text] [Related]
4. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
Shen L; Potter TA; Kane KP
J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
[TBL] [Abstract][Full Text] [Related]
5. Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.
Yang S; Tsang KY; Schlom J
Clin Cancer Res; 2005 Aug; 11(15):5603-15. PubMed ID: 16061879
[TBL] [Abstract][Full Text] [Related]
6. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.
Foley MH; Forcier T; McAndrew E; Gonzalez M; Chen H; Juelg B; Walker BD; Irvine DJ
PLoS One; 2014; 9(2):e87873. PubMed ID: 24551068
[TBL] [Abstract][Full Text] [Related]
7. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.
Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Berzofsky JA
J Immunol; 2007 Jun; 178(11):7211-21. PubMed ID: 17513770
[TBL] [Abstract][Full Text] [Related]
8. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity.
Sandberg JK; Franksson L; Sundbäck J; Michaelsson J; Petersson M; Achour A; Wallin RP; Sherman NE; Bergman T; Jörnvall H; Hunt DF; Kiessling R; Kärre K
J Immunol; 2000 Jul; 165(1):25-33. PubMed ID: 10861031
[TBL] [Abstract][Full Text] [Related]
9. Viral peptide specific cytotoxic T lymphocytes are of high avidity to host-MHC but only low avidity to donor-MHC after allogeneic bone marrow transplantation.
Kyburz D; Speiser DE
Transpl Immunol; 1995 Jun; 3(2):143-50. PubMed ID: 7582905
[TBL] [Abstract][Full Text] [Related]
10. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
11. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
12. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
[TBL] [Abstract][Full Text] [Related]
13. Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity.
Cawthon AG; Alexander-Miller MA
J Immunol; 2002 Oct; 169(7):3492-8. PubMed ID: 12244138
[TBL] [Abstract][Full Text] [Related]
14. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.
Alexander-Miller MA; Leggatt GR; Berzofsky JA
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4102-7. PubMed ID: 8633023
[TBL] [Abstract][Full Text] [Related]
15. Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells.
Macatonia SE; Patterson S; Knight SC
Immunology; 1991 Nov; 74(3):399-406. PubMed ID: 1769689
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells endowed with professional antigen-presenting cell functions prime PBLs to generate antitumor CTLs.
Chiozzini C; Olivetta E; Sanchez M; Arenaccio C; Ferrantelli F; Leone P; Federico M
J Mol Med (Berl); 2019 Aug; 97(8):1139-1153. PubMed ID: 31161312
[TBL] [Abstract][Full Text] [Related]
17. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL.
Lee K; Takenaka H; Yoneda Y; Goto T; Sano K; Nakanishi M; Eguchi A; Okada M; Tashiro J; Sakurai K; Kubota T; Yoshida R
Microbiol Immunol; 2004; 48(1):15-25. PubMed ID: 14734854
[TBL] [Abstract][Full Text] [Related]
19. Antimelanoma activity of CTL generated from peripheral blood mononuclear cells after stimulation with autologous dendritic cells pulsed with melanoma gp100 peptide G209-2M is correlated to TCR avidity.
Yang S; Linette GP; Longerich S; Haluska FG
J Immunol; 2002 Jul; 169(1):531-9. PubMed ID: 12077285
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae.
Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M
Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]